Search research articles
Contact Us
Filters
Showing results (121-130 of 223) with videos related to
Page
of 23
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 10, 2022
ABO blood group distribution and risk of malignancy in patients undergoing resection for intraductal papillary mucinous neoplasm (IPMN)
Piotr Zelga, Yasmin G Hernández-Barco, Motaz Qadan, et al.
American Journal of Surgery
|
June 26, 2020
Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases
Derek J Erstad, Martin S Taylor, Motaz Qadan, et al.
Annals of Surgery
|
April 8, 2025
Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma with Non-elevated Carbohydrate Antigen 19-9 Levels
Guoliang Qiao, Xiang Li, Marwa Mohamed, et al.
Surgery
|
November 10, 2023
Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Journal of the American College of Surgeons
|
June 15, 2022
Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm
Piotr Zelga, Yasmin G Hernandez-Barco, Motaz Qadan, et al.
Annals of Surgery
|
December 11, 2025
Long-term Outcomes of Spleen-preserving Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Bi-institutional Experience
Shahrzad Arya, Marco Ventin, Liti Zhang, et al.
Annals of Surgery
|
July 2, 2024
Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 17, 2019
Does preoperative pharmacologic prophylaxis reduce the rate of venous thromboembolism in pancreatectomy patients?
Zhi V Fong, Naomi M Sell, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery
|
December 26, 2021
Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy
Fidel Lopez-Verdugo, Zhi Ven Fong, Keith D Lillemoe, et al.
Surgery
|
February 23, 2023
Identification of high-risk features in mucinous cystic neoplasms of the pancreas
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 223) with videos related to
Sort By:
Page
of 23
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 10, 2022
ABO blood group distribution and risk of malignancy in patients undergoing resection for intraductal papillary mucinous neoplasm (IPMN)
Piotr Zelga, Yasmin G Hernández-Barco, Motaz Qadan, et al.
American Journal of Surgery
|
June 26, 2020
Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases
Derek J Erstad, Martin S Taylor, Motaz Qadan, et al.
Annals of Surgery
|
April 8, 2025
Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma with Non-elevated Carbohydrate Antigen 19-9 Levels
Guoliang Qiao, Xiang Li, Marwa Mohamed, et al.
Surgery
|
November 10, 2023
Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Journal of the American College of Surgeons
|
June 15, 2022
Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm
Piotr Zelga, Yasmin G Hernandez-Barco, Motaz Qadan, et al.
Annals of Surgery
|
December 11, 2025
Long-term Outcomes of Spleen-preserving Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Bi-institutional Experience
Shahrzad Arya, Marco Ventin, Liti Zhang, et al.
Annals of Surgery
|
July 2, 2024
Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 17, 2019
Does preoperative pharmacologic prophylaxis reduce the rate of venous thromboembolism in pancreatectomy patients?
Zhi V Fong, Naomi M Sell, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery
|
December 26, 2021
Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy
Fidel Lopez-Verdugo, Zhi Ven Fong, Keith D Lillemoe, et al.
Surgery
|
February 23, 2023
Identification of high-risk features in mucinous cystic neoplasms of the pancreas
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, et al.
Page
of 23